Renal Stone. Calculus of kidney
Conditions
Interventions
This study has no control group.The intervention group consisted of subjects with renal stone that had a history of recurrent stone formation for 8 weeks receiving one gram of oral vial L-carnitine d
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with a history of renal stone passage Patients undergoing surgical or non-surgical (ESWL) surgery for kidney or ureteral stones
Exclusion criteria
Exclusion criteria: Patients with anatomical disorders Patients who first have kidney stones Patients with endocrine disorders including hyperparathyroidism, diabetes mellitus, metabolic syndrome, cystinuria .. Patients who have been on medications other than L-carnitine for kidney or ureteral stones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24 hour urine calcium. Timepoint: Before intervention and 8 weeks after starting L-carnitine vial. Method of measurement: Colorimetric.;24 hour urine oxalate. Timepoint: Before intervention and 8 weeks after starting L-carnitine vial. Method of measurement: Colorimetric.;24 hour urine uric acid. Timepoint: Before intervention and 8 weeks after starting L-carnitine vial. Method of measurement: Colorimetric.;24 hour urine citrate. Timepoint: Before intervention and 8 weeks after starting L-carnitine vial. Method of measurement: Colorimetric. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaser Tabibian
Ahvaz University of Medical Sciences
Outcome results
None listed